Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
WASHINGTON, Nov 13 (Reuters) - U.S. President Donald Trump said on Friday he expects a coronavirus vaccine to be available for the entire population as soon as April, amid a crush of new infections of the deadly disease that has pushed daily case ...
Read more
(Sharecast News) - European shares finished a week of rampant gains on a positive note, helped by reports that the second wave of Covid-19 cases in Belgium and France might be breaking.
Read more(Sharecast News) - Covid-19 test positivity is increasing rapidly and may necessitate that most large-population states impose more severe restrictions, a top-ranked US economist said.
Read more(Adds details)ZURICH, Nov 13 (Reuters) - Switzerland has begun a rolling review of Moderna's, COVID-19 vaccine candidate so it can give it a speedy approval should it pass muster in clinical trials, the country's drug regulator said on Friday.Regu...
Read moreBy Steve StecklowLONDON, Nov 12 (Reuters) - So why did I volunteer to be injected with an experimental vaccine for COVID-19? That's what some of my friends wanted to know when I told them what I was doing."Who knows about the long term," texted a ...
Read more* Calquence fails to meet main goal in mid-stage COVID-19 trials* Approved indications or pending approvals for Calquence not hit* Drugmaker remains committed to COVID-19 vaccine trials (Adds details on the trial, drug, background)By Aakash BNov 1...
Read more
Irish Government Sets Up Taskforce To Oversee Rollout Of Vaccine
Read more(Adds details, comment from Swiss health minister)ZURICH, Nov 11 (Reuters) - Switzerland has reserved 16 million doses of potential COVID-19 vaccines, the government said on Wednesday, announcing a new 3.2 million-dose reservation with a World Hea...
Read moreZURICH, Nov 11 (Reuters) - Switzerland now has reserved around 16 million doses of potential COVID-19 vaccines, the government said on Wednesday, after announcing a 3.2 million-dose reservation with a World Health Organization-led program and ano...
Read more* European shares rise, +13% so far in November* Tech stocks recover, despite Prosus' China woes* Banks take a break after best run since 2008* Goldman lifts S&P 500, STOXX, FTSE targets* Wall Street futures point to higher open Welcome to the home ...
Read moreZURICH, Nov 11 (Reuters) - Switzerland increased funds it has set aide to buy vaccines against COVID-19 to 400 million Swiss francs ($436 million), from 300 million francs previously, saying on Wednesday the additional infusion is necessary to en...
Read more* European shares rise, +13% so far in November* Tech stocks recover, despite Prosus' China woes* Banks take a break after best run since 2008* Goldman lifts S&P 500, STOXX, FTSE targets* Wall Street futures point to higher open Welcome to the home ...
Read more(adds details)HONG KONG/BEIJING, Nov 11 (Reuters) - China's Tibet Rhodiola Pharmaceutical Holding announced a deal on Wednesday to manufacture, sell and test Russia's COVID-19 vaccine in China, hours after interim results showed it was 92% effecti...
Read more(Adds details)HONG KONG/BEIJING, Nov 11 (Reuters) - China's Tibet Rhodiola Pharmaceutical Holding announced a deal on Wednesday to manufacture, sell and test Russia's COVID-19 vaccine in China, hours after interim results showed it was 92% effecti...
Read more(Adds details on the deal, context on vaccine development partnerships)HONG KONG/BEIJING, Nov 11 (Reuters) - Chinese firm Tibet Rhodiola Pharmaceutical Holding said on Wednesday it had obtained the non-exclusive rights to develop, manufacture, im...
Read more
Last checked at